Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Sector Gamma As
Form 13F · Q2 2026

Sector Gamma As

CIK 1475373Filed 2026-08-1213F-HR View the filing on EDGAR ↗
$461M
Reported book value
40
Positions
12
Quarters on record
Top 50
Positions

Sector Gamma As — holdings

Top 40 positions of 40, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1BMY Bristol-Myers Squibb Co726,115−12.3%$42M9.1%
2MRK Merck & Co Inc217,008−16.6%$28M6.0%
3MDT Medtronic Plc352,437+25.6%$28M6.0%
4PFE Pfizer Inc1.0M−8.0%$24M5.2%
5INCY Incyte Corp170,753−14.8%$19M4.2%
6ELV Elevance Health Inc Formerly44,499+1.2%$17M3.7%
7BMRN Biomarin Pharmaceutical Inc294,918+22.9%$17M3.7%
8TMO Thermo Fisher Scientific Inc33,584—$17M3.7%
9CVS Cvs Health Corp155,337+14.8%$16M3.5%
10IQV Iqvia Hldgs Inc77,944+93.7%$15M3.3%
11IONS Ionis Pharmaceuticals Inc189,468+11.8%$15M3.3%
12BDX Becton Dickinson & Co93,168+12.8%$14M3.1%
13ABT Abbott Laboratories147,444+68.4%$13M2.9%
14GEHC Ge Healthcare Technologies I207,863+64.4%$13M2.9%
15ZBH Zimmer Biomet Holdings Inc142,307−8.7%$12M2.7%
16BIIB Biogen Inc54,163−39.9%$12M2.5%
17QGEN Qiagen Nv287,640+77.1%$11M2.4%
18CNC Centene Corp Del162,405+0.0%$10M2.3%
19REGN Regeneron Pharmaceuticals15,780—$10M2.1%
20BIO Bio Rad Labs Inc33,350+40.4%$10M2.1%
21CAH Cardinal Health Inc40,689−25.9%$10M2.1%
22AMGN Amgen Inc26,281−44.3%$10M2.1%
23BRKR Bruker Corp152,352−40.0%$9M2.0%
24AVTR Avantor Inc906,088+30.3%$9M1.9%
25PTCT Ptc Therapeutics Inc100,000+33.3%$8M1.8%
26LH Labcorp Holdings Inc26,019+36.8%$7M1.6%
27DXCM Dexcom Inc102,122+82.0%$7M1.5%
28ASND Ascendis Pharma A/S21,305—$6M1.2%
29EW Edwards Lifesciences Corp60,402+0.0%$5M1.2%
30SNDX Syndax Pharmaceuticals Inc241,739−15.5%$5M1.1%
31BSX Boston Scientific Corp121,128—$5M1.1%
32KURA Kura Oncology Inc433,012+5.1%$5M1.0%
33TVTX Travere Therapeutics Inc80,000—$5M1.0%
34CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In114,628+21.7%$4M0.9%
35TNDM Tandem Diabetes Care Inc267,091+0.0%$4M0.9%
36IOVA Iovance Biotherapeutics Inc968,466+7.6%$4M0.9%
37CYTK Cytokinetics Inc45,000—$4M0.8%
38OGN Organon & Co270,781−28.0%$4M0.8%
39ARDX Ardelyx Inc686,844+33.1%$4M0.8%
40NTLA Intellia Therapeutics Inc185,177—$3M0.7%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.